Back
Day Range
$565.33
$576.51
52-Week Range
$356.14
$769.98
Volume
360,674
50D / 200D Avg
$647.35
/
$635.19
Prev Close
$578.51
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 43.0 | 0.4 |
| P/B | 28.4 | 2.9 |
| ROE % | 66.2 | 3.7 |
| Net Margin % | 24.6 | 3.9 |
| Rev Growth 5Y % | 7.6 | 10.0 |
| D/E | 0.7 | 0.2 |
Analyst Price Target
Hold
$784.38
+37.6%
Low: $730.00
High: $830.00
Forward P/E
39.7
Forward EPS
$14.56
EPS Growth (est.)
+0.0%
Est. Revenue
4.7 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$26.21
$25.95 – $26.56
|
7 B | 6 |
| FY2029 |
$21.46
$21.24 – $21.74
|
6.2 B | 6 |
| FY2028 |
$18.75
$17.56 – $19.89
|
5.6 B | 8 |
Key Takeaways
Revenue grew 7.56% annually over 5 years — modest growth
Earnings grew 19.33% over the past year
ROE of 66.20% indicates high profitability
Net margin of 24.62% shows strong profitability
Generating 1.05B in free cash flow
P/E of 42.98 — premium valuation
Growth
Revenue Growth (5Y)
7.56%
Revenue (1Y)10.42%
Earnings (1Y)19.33%
FCF Growth (3Y)16.75%
Quality
Return on Equity
66.20%
ROIC38.02%
Net Margin24.62%
Op. Margin31.60%
Safety
Debt / Equity
0.67
Current Ratio1.17
Interest Coverage35.54
Valuation
P/E Ratio
42.98
P/B Ratio28.36
EV/EBITDA34.14
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.42% | Revenue Growth (3Y) | 8.42% |
| Earnings Growth (1Y) | 19.33% | Earnings Growth (3Y) | 11.97% |
| Revenue Growth (5Y) | 7.56% | Earnings Growth (5Y) | 9.21% |
| Profitability | |||
| Revenue (TTM) | 4.30B | Net Income (TTM) | 1.06B |
| ROE | 66.20% | ROA | 31.62% |
| Gross Margin | 61.80% | Operating Margin | 31.60% |
| Net Margin | 24.62% | Free Cash Flow (TTM) | 1.05B |
| ROIC | 38.02% | FCF Growth (3Y) | 16.75% |
| Safety | |||
| Debt / Equity | 0.67 | Current Ratio | 1.17 |
| Interest Coverage | 35.54 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 42.98 | P/B Ratio | 28.36 |
| P/S Ratio | 10.58 | PEG Ratio | 2.30 |
| EV/EBITDA | 34.14 | Dividend Yield | 0.00% |
| Market Cap | 45.53B | Enterprise Value | 46.43B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.30B | 3.90B | 3.66B | 3.37B | 3.22B |
| Net Income | 1.06B | 887.87M | 845.04M | 679.09M | 744.85M |
| EPS (Diluted) | 13.08 | 10.67 | 10.06 | 8.03 | 8.60 |
| Gross Profit | 2.66B | 2.38B | 2.19B | 2.00B | 1.89B |
| Operating Income | 1.36B | 1.13B | 1.10B | 898.77M | 932.03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.35B | 3.29B | 3.26B | 2.75B | 2.44B |
| Total Liabilities | 1.75B | 1.70B | 1.78B | 2.14B | 1.75B |
| Shareholders' Equity | 1.61B | 1.60B | 1.48B | 608.74M | 689.99M |
| Total Debt | 1.08B | 986.95M | 1.07B | 1.47B | 1.03B |
| Cash & Equivalents | 180.07M | 288.27M | 453.93M | 112.55M | 144.45M |
| Current Assets | 1.34B | 1.40B | 1.50B | 1.10B | 955.66M |
| Current Liabilities | 1.15B | 1.07B | 951.55M | 1.24B | 763.58M |